Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine

Behavioural Pharmacology

Volumn 25, Issue 1, 2014, Pages 12-22

  Henry, Brook L ^a   Geyer, Mark A ^a,b   Buell, Mahalah R ^a   Perry, William ^a   Young, Jared W ^a,b   Minassian, Arpi ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c Center of Excellence for Stress and Mental Health (CESAMH)   (United States)

Author keywords

gp120; HIV; methamphetamine; mouse; prepulse inhibition; sensorimotor gating

Indexed keywords

GLYCOPROTEIN GP 120; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG WITHDRAWAL; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOUSE; NONHUMAN; PHARMACOGENETICS; PREPULSE INHIBITION; SENSORY GATING; STARTLE REFLEX; SUBSTANCE USE; TRANSGENIC MOUSE; WILD TYPE;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV ENVELOPE PROTEIN GP120; HUMANS; LAMENESS, ANIMAL; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURAL INHIBITION; SEX FACTORS; STARTLE REACTION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 84891853122     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000012     Document Type: Article

References (63)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799. (Pubitemid 350059308)
2. Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Takahashi K, et al. (2008). Involvement of pallidotegmental neurons in methamphetamine-and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacol 33:3164-3175.
3. Bhatt SD, Dluzen DE (2005). Dopamine transporter function differences between male and female CD-1 mice. Brain Res 1035:188-195. (Pubitemid 40250190)
4. Braff DL, Geyer MA (1990). Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiat 47:181-188. (Pubitemid 20058094)
5. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234-258. (Pubitemid 32705488)
6. Cadet JL, Krasnova IN (2007). Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation. Neurotox Res 12:181-204.
7. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I (2006). Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 10:185-190.
8. Cattie JE, Woods SP, Iudicello JE, Posada C, Grant I (2012). Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users. J Neuropsych Clin N 24: 331-339.
9. Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, et al. (2006). Cognitive deficits and degeneration of interneurons in HIV + methamphetamine users. Neurology 67:1486-1489. (Pubitemid 44632083)
10. Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M, Miller E (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviralnaive HIV patients. Neuroimage 17:1638-1648. (Pubitemid 35333882)
11. Chang L, Ernst T, Speck O, Grob CS (2005). Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiat 162:361-369. (Pubitemid 40216218)
12. Chao YL, Chen HH, Chen CH (2012). Effects of repeated electroconvulsive shock on methamphetamine-induced behavioral abnormalities in mice. Brain Stimul 5:393-401.
13. Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, Sung YH, et al. (2007). Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol 10:765-775. (Pubitemid 350035821)
14. D'Hooge R, Franck F, Mucke L, De Deyn PP (1999). Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur J Neurosci 11:4398-4402. (Pubitemid 30009272)
15. Dalley JW, Laane K, Theobald DE, Pena Y, Bruce CC, Huszar AC, et al. (2007). Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacol 32:1195-1206. (Pubitemid 46631979)
16. Druhan JP, Geyer MA, Valentino RJ (1998). Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology (Berl) 135:296-304. (Pubitemid 28055466)
17. Feifel D, Minassian A, Perry W (2009). Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res 43:484-489.
18. Fitting S, Booze RM, Hasselrot U, Mactutus CF (2006a). Intrahippocampal injections of Tat: effects on prepulse inhibition of the auditory startle response in adult male rats. Pharmacol Biochem Behav 84:189-196. (Pubitemid 44137300)
19. Fitting S, Booze RM, Mactutus CF (2006b). Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response. Int J Dev Neurosci 24:275-283. (Pubitemid 44226328)
20. Fitting S, Booze RM, Mactutus CF (2006c). Neonatal intrahippocampal glycoprotein 120 injection: the role of dopaminergic alterations in prepulse inhibition in adult rats. J Pharmacol Exp Ther 318:1352-1358. (Pubitemid 44268345)
21. Fitting S, Booze RM, Mactutus CF (2007). Neonatal intrahippocampal gp120 injection: an examination early in development. Neurotoxicology 28:101-107. (Pubitemid 46187261)
22. Geyer MA, Swerdlow NR (2001). Measurement of startle response, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P, editors. Current Protocols in Neuroscience. New York: John Wiley & Sons. pp. 8.17.1-8.17.15.
23. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-154. (Pubitemid 32702206)
24. Geyer MA, Dulawa SC (2003). Assessment of murine startle reactivity, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P, editors. Current Protocols in Neuroscience. New York: John Wiley & Sons. pp. 8.17.1-8.17.15.
25. Goodwin FK, Jamison KR (1990). Manic-depressive illness. New York: Oxford UP.
26. Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, et al. (2012). Dysregulation of D(2)-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci 32:5843-5852.
27. Henry BL, Geyer MA, Buell M, Perry W, Young JW, Minassian A (2013). Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res 236:210-220.
28. Ison JR, Allen PD (2007). Pre-but not post-menopausal female CBA/CaJ mice show less prepulse inhibition than male mice of the same age. Behav Brain Res 185:76-81. (Pubitemid 47633695)
29. Iudicello JE,Woods SP, Vigil O, Scott JC, Cherner M, Heaton RK, et al. (2010). Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. J Clin Exp Neuropsychol 32:704-718.
30. Koch M (1998). Sensorimotor gating changes across the estrous cycle in female rats. Physiol Behav 64:625-628. (Pubitemid 28470578)
31. Kuczenski R, Everall IP, Crews L, Adame A, Grant I, Masliah E (2007). Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp Neurol 207:42-51. (Pubitemid 47332481)
32. Maung R, Medders KE, Sejbuk NE, Desai MK, Russo R, Kaul M (2012). Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury. J Neuroimmune Pharmacol 7:306-318.
33. Meade CS,Watt MH, Sikkema KJ, Deng LX, Ranby KW, Skinner D, et al. (2012). Methamphetamine use is associated with childhood sexual abuse and HIV sexual risk behaviors among patrons of alcohol-serving venues in Cape Town, South Africa. Drug Alcohol Depend 126:232-239.
34. Milesi-Halle A, Hendrickson HP, Laurenzana EM, Gentry WB, Owens SM (2005). Sex-and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats. Toxicol Appl Pharmacol 209:203-213. (Pubitemid 41713945)
35. Minassian A, Henry BL, Woods SP, Vaida F, Grant I, Geyer MA, et al. (2013). Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc 19:709-717.
36. Monterosso JR, Aron AR, Cordova X, Xu J, London ED (2005). Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 79:273-277. (Pubitemid 40942119)
37. Moran LM, Aksenov MY, Booze RM,Webb KM, Mactutus CF (2012). Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res 10:415-424.
38. Moran LM, Booze RM, Webb KM, Mactutus CF (2013). Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol 239:139-147.
39. Murphy CA, Fend M, Russig H, Feldon J (2001). Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 115:1247-1256. (Pubitemid 33139132)
40. Nakato Y, Abekawa T, Ito K, Inoue T, Koyama T (2010). Lamotrigine blocks the initiation and expression of repeated high-dose methamphetamine-induced prepulse inhibition deficit in rats. Neurosci Lett 481:183-187.
41. Peleg-Raibstein D, Sydekum E, Russig H, Feldon J (2006). Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition. J Neural Transm 113:1323-1336. (Pubitemid 44291025)
42. Perry W, Minassian A, Feifel D, Braff DL (2001). Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiat 50: 418-424. (Pubitemid 32885591)
43. Polich J, Ilan A, Poceta JS, Mitler MM, Darko DF (2000). Neuroelectric assessment of HIV: EEG, ERP, and viral load. Int J Psychophysiol 38:97-108.
44. Powell SB, Young JW, Ong JC, Caron MG, Geyer MA (2008). Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol 19:562-565.
45. Ralph RJ, Varty GB, Kelly MA,Wang YM, Caron MG, Rubinstein M, et al. (1999). The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 19:4627-4633. (Pubitemid 29241110)
46. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10:1-14. (Pubitemid 38128457)
47. Russig H, Murphy CA, Feldon J (2003). Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine. Psychopharmacology (Berl) 169:340-353. (Pubitemid 37264945)
48. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, et al. (2002). Preliminary evidence of reduced cognitive inhibition in methamphetaminedependent individuals. Psychiat Res 111:65-74. (Pubitemid 34874482)
49. Segal DS, Kuczenski R (1997). An escalating dose 'binge' model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17:2551-2566. (Pubitemid 27137421)
50. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK (2003). Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacol 28:1730-1740. (Pubitemid 41070838)
51. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK (2005). Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization. Psychopharmacology (Berl) 180:501-512. (Pubitemid 40905039)
52. Semple SJ, Zians J, Grant I, Patterson TL (2006). Methamphetamine use, impulsivity, and sexual risk behavior among HIV-positive men who have sex with men. J Addict Dis 25:105-114. (Pubitemid 44707294)
53. Singer P, Hauser J, Llano Lopez L, Peleg-Raibstein D, Feldon J, Gargiulo PA, et al. (2013). Prepulse inhibition predicts working memory performance whilst startle habituation predicts spatial reference memory retention in C57BL/6 mice. Behav Brain Res 242:166-177.
54. Tenn CC, Fletcher PJ, Kapur S (2003). Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64:103-114. (Pubitemid 37412332)
55. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994). Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193. (Pubitemid 24031702)
56. Varty GB, Powell SB, Lehmann-Masten V, Buell MR, Geyer MA (2006). Isolation rearing of mice induces deficits in prepulse inhibition of the startle response. Behav Brain Res 169:162-167. (Pubitemid 43277482)
57. Willott JF, Tanner L, O'Steen J, Johnson KR, Bogue MA, Gagnon L (2003). Acoustic startle and prepulse inhibition in 40 inbred strains of mice. Behav Neurosci 117:716-727. (Pubitemid 36935383)
58. Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL, et al. (2005). Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19: 35-43. (Pubitemid 40144311)
59. Yamashita M, Fukushima S, Shen HW, Hall FS, Uhl GR, Numachi Y, et al. (2006). Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacol 31:2132-2139. (Pubitemid 44413190)
60. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA (2009). Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122:150-202.
61. Young JW, Goey AK, Minassian A, PerryW, Paulus MP, Geyer MA (2010a). GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl) 208: 443-454.
62. Young JW, Wallace CK, Geyer MA, Risbrough VB (2010b). Age-associated improvements in cross-modal prepulse inhibition in mice. Behav Neurosci 124:133-140.
63. Young JW, Powell SB, Scott CN, Zhou X, Geyer MA (2011). The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding. Behav Brain Res 222:183-192.